// App-Quantinova.ai

O-9 : Discordant prognostic significance of negative lymph node size in patients with oesophageal cancer treated with either surgery or neoadjuvant chemotherapy and surgery: Results from the MRC OE02 trial

Researchers

Presenter

  • M. Kloft

Principal Investigators

  • J. Ruisch

  • M. Nankivell

  • W. Allum

  • D. Cunningham

  • R. Langley

  • H. Grabsch

Medical Centers

  • Department of Medical Oncology, Maastricht University Medical Center, Maastricht, Netherlands

  • MRC Clinical Trials Unit, UCL, London, United Kingdom

  • Department of Academic Surgery, Royal Marsden Hospital NHS, London, United Kingdom

  • Gastrointestinal and Lymphoma Unit, Royal Marsden Hospital, London, United Kingdom

  • Maastricht University Medical Center, Maastricht, Netherlands

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved